Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8, 2021
Evofem Biosciences, Inc. (NASDAQ: EVFM) announced that CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on June 8, 2021, at 1:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Evofem Biosciences, Inc. (NASDAQ: EVFM) announced that CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on June 8, 2021, at 1:00 p.m. ET. The presentation will focus on the commercialization of Evofem's hormone-free contraceptive Phexxi®, the Phase 3 clinical trial for EVO100 to prevent chlamydia and gonorrhea in women, and other initiatives. Interested participants can pre-register for the presentation at ldmicrojune2021.mysequire.com.
Details
News Market Reaction – EVFM
The recorded move for EVFM in the trading session of this news was -2.70%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 25, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that its CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on Tuesday, June 8, 2021 at 1:00 p.m. ET (10:00 a.m. PT).
Pelletier will provide an update on the commercialization of Evofem's hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), the ongoing Phase 3 clinical trial evaluating EVO100 for the prevention of chlamydia and gonorrhea in women, and other ongoing initiatives.
To pre-register for the presentation, please visit https://ldmicrojune2021.mysequire.com/.
About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). For more information, please visit evofem.com.
Phexxi® is a registered trademark of Evofem Biosciences, Inc.
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775
View original content to download multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-ld-micro-invitational-xi-on-tuesday-june-8-2021-301298297.html
SOURCE Evofem Biosciences, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.